10x Genomics, Inc.
TXG
$9.42
$0.313.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.69% | -0.16% | 61.55% | 39.28% | -18.13% |
| Total Depreciation and Amortization | -14.62% | -9.76% | -5.87% | -8.23% | 33.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.55% | -27.96% | -16.06% | -21.22% | -11.23% |
| Change in Net Operating Assets | 549.10% | -108.06% | -19.65% | 59.08% | -5.65% |
| Cash from Operations | 318.45% | -126.20% | 185.52% | 165.04% | -281.21% |
| Capital Expenditure | 34.95% | 21.28% | 74.47% | 88.65% | 36.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -395.36% | -98.65% | -29.05% | -89.12% |
| Cash from Investing | -117.80% | -493.89% | -173.84% | 367.75% | -91.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -74.24% | -19.53% | -96.43% | -35.13% | -31.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -74.24% | -19.53% | -96.43% | -35.13% | 147.98% |
| Foreign Exchange rate Adjustments | 337.50% | -449.35% | 283.53% | 93.88% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,041.88% | -221.43% | 213.78% | 368.91% | -103.12% |